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Abstract
Bioactive milk peptides are reported to illicit a range of physiological benefits
and have been proposed as potential functional food ingredients. The objective
of this study was to characterize the anti-inflammatory properties of sodium
caseinate (NaCAS), its enzyme hydrolysate (EH) and peptide-enriched fractions
(5 kDa retentate [R], 1 kDaR and 1 kDa permeate [P]), both in vitro using a
Caco-2 cell line, and also ex vivo using a porcine colonic tissue explant system.
Caco-2 cells were stimulated with tumour necrosis factor alpha (TNFa) and co-
treated with casein hydrolysates for 24 h. Following this, interleukin (IL)-8 con-
centrations in the supernatant were measured using enzyme-linked immunosor-
bent assay. Porcine colonic tissue was stimulated with lipopolysaccharide and
co-treated with casein hydrolysates for 3 h. The expression of a panel of inflam-
matory cytokines was measured using qPCR. While dexamethasone reduced the
IL-8 concentration by 41.6%, the 1 kDaR and 1 kDaP fractions reduced IL-8
by 68.7% and 66.1%, respectively, relative to TNFa-stimulated Caco-2 cells
(P < 0.05). In the ex vivo system, only the 1 kDaR fraction elicited a decrease
in IL1-a, IL1-b, IL-8, TGF-b and IL-10 expression (P < 0.05). This study pro-
vides evidence that the bioactive peptides present in the 1 kDaR fraction of the
NaCAS hydrolysate possess anti-inflammatory properties in vitro and ex vivo.
Further in vivo analysis of the anti-inflammatory properties of the 1 kDaR is
proposed.
Introduction
Milk is an emulsion of milk fat globules within a water-
based fluid of dissolved carbohydrates, minerals and sus-
pended protein particles. While whole milk is a valuable
source of nutrition (Mills et al. 2011), there is also a high
incidence of allergic symptoms and lactose intolerance in
individuals (Haug et al. 2007). The digestion/hydrolysis
of milk proteins can yield physiologically important
bioactive peptides that have a wide range of biological
activities which have been researched extensively in an
effort to isolate bioactive ingredients suitable for func-
tional foods (Fox 2001; Madureira et al. 2010; Abete et al.
2011; Phelan and Kerins 2011; Jakubowicz and Froy
2013). These bioactive peptides can be released in vivo by
digestion in the gastrointestinal tract or in vitro by
fermentation or enzymatic hydrolysis from parent milk
proteins (Phelan and Kerins 2011). Casein is a major pro-
tein in cow’s milk and constitutes about 80% of the total
milk protein. Milk bioactives generated from either
sodium caseinate (NaCAS) or whey protein are of interest
because they are low in lactose and thus have potential as
an alternative milk source for lactose intolerant individu-
als (Sindayikengera 2006).
Several studies have used in vitro gastrointestinal cell
models, such as human colonic adenocarcinoma cells
(Caco-2 cells) to evaluate the bioactivity of milk
hydrolysates: whey protein isolates were identified with
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anti-inflammatory effects in Caco-2 cells stimulated with
hydrogen peroxide (Piccolomini et al. 2012); also a 3-kDa
fermentate of NaCAS, generated from the fermentation of
lactic acid bacteria, activated the transcription factor
NFjB in Caco-2 cells (Stuknyte et al. 2011). Although
Caco-2 cells functionally resemble colonic enterocytes,
this monolayer of cells lacks immune cells in the basolat-
eral side of the epithelium. Thus, while Caco-2 cells are a
useful model of the gastro-intestinal tract (GIT), this
model lacks the cellular heterogeneity, present in vivo.
Hence, intestinal tissue explants are also used to model
the GIT to further validate the in vitro outcomes (Bahar
et al. 2012; Girard-Misguich et al. 2012) and to provide
an alternative insight into the effects of bioactive com-
pounds on signaling factors and cytokines active within
the entire tissue and all the cell types within it (Randall
et al. 2011). The RNA present in porcine colonic explants
remains stable for 3 h following an lipopolysaccharide
(LPS) challenge (Bahar et al. 2012). Hence, this colonic
ex vivo system can be applied to evaluate the effects of
bioactive compounds on inflammatory cytokine gene
expression (Bahar et al. 2012).
A number of cytokines from distinct T-cell subsets
(Th1, Th2, Th17 and Treg) plays a central role in intesti-
nal immunology (Roberts-Thomson et al. 2011). Imbal-
ances in these T-cell subsets and their cytokines are
central to the etiology of chronic inflammatory bowel dis-
eases (IBDs), including Crohn’s and colitis (Powrie 2012)
where either inadequate or prolonged activation of the
immune system results in chronic mucosal inflammation
(Rogler and Andus 1998). Plasma interleukin (IL)-8 has
been shown to correlate with intestinal inflammation,
establishing it as an important marker of inflammation
(Scherl and Longman 2012). Tumor necrosis factor alpha
(TNFa) is also implicated as a key player in the
progression of IBD (Rogler and Andus 1998). Chronic
inflammatory disorders, such as IBD, which are generally
treated with steroids and immunosuppressants, can have
undesirable side effects, considerable toxicity and variable
outcomes with respect to controlling symptoms (Rogler
2010). Therefore, natural and safer alternatives are
continuously being sought as a means of alleviating IBD
symptoms (Khan et al. 2012).
A number of NaCAS hydrolysate fractions with distinct
physico-chemical properties have recently been generated
in our group. The overall objective of this study was to
determine if these fractions have anti-inflammatory
biological activity in vitro and ex vivo. Hence, the first
objective of this study was to characterize the anti-inflam-
matory effects of NaCAS and a NaCAS enzyme hydroly-
sate (EH) along with its associated 5 kDa retentate
(5 kDaR), 1 kDa retentate (1 kDaR) and 1 kDa permeate
(1 kDaP) fractions in an Caco-2 cell line stimulated with
TNFa. The second objective of this study was to
characterize the anti-inflammatory effects of the same
NaCAS and its fractions in ex vivo LPS-challenged
porcine colonic tissues.
Materials and Methods
Generation of a NaCAS hydrolysate
NaCAS (90% w/w protein, Kerry Food Ingredients, Lis-
towel, Ireland) from bovine milk was suspended at 10%
(w/w) on a protein basis in distilled water and dispersed
under agitation at 50°C for 1 h using an overhead stirrer
(Heidolph RZR 1, Schwabach, Germany). The pH was
adjusted to 7.0 using a NaOH 4.0 N solution (VWR,
Dublin, Ireland). A bacterial food-grade enzyme prepara-
tion was added to the protein solution and hydrolysis was
carried out at constant pH (7.0) by manual titration of
4.0 N NaOH, until the desired degree of hydrolysis (DH)
was achieved. The enzyme was inactivated by heat treat-
ment of the hydrolysate sample at 85°C for 25 sec. All
hydrolysis experiments were conducted in triplicate. The
hydrolysate (50 L) described above was dehydrated in a
pilot scale Anhydro Lab 3 spray drier (SPX Flow Technol-
ogy A/S, Soeborg, Denmark) at an inlet temperature
range of 185–190°C and outlet of 85–90°C. The EH was
further concentrated (to ca 40% total solids) before spray
drying, as outlined above, in a Anhydro F1 Lab single-
effect falling film evaporator (SPX Flow Technology).
Membrane processing of the casein
hydrolysate
The milk hydrolysate was subjected to microfiltration
(MF) using a GEA Model F unit (GEA Process Engineer-
ing A/S, Skanderborg, Denmark). This unit was fitted
with three ceramic membranes (Tami Industries, Nyons
Cedex, France) having a nominal molecular weight cut
off of 0.14 lm. MF was carried out at 50°C and pH 7 to
a volume concentration factor (VCF) of 8. A feed recircu-
lation rate of 1500 L h1 at 1 bar and a membrane inlet
pressure of 4.2 bar were maintained throughout process-
ing. The permeate stream prepared above was then sub-
jected to ultrafiltration (UF) using the same GEA model
F unit fitted with two spiral wound membranes (Koch
Membrane Systems, Wilmington, MA). These membranes
have a nominal molecular weight cut off of 5 kDa. The
5 kDa permeate stream was finally processed on the GEA
model F plant fitted with two spiral wound membranes
(Alpha Laval AB, Lund, Sweden). These membranes have
a nominal molecular weight cut off of 1 kDa. UF was
carried out at 50°C and pH 7 to a VCF of 7. A feed recir-
culation rate of 1500 L h-1 at 1 bar and membrane inlet
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pressure of 5 bar were maintained throughout processing.
The 0.14 lm and 5 kDaR streams described above were
dehydrated in a pilot scale Anhydro Lab 3 spray drier
(SPX Flow Technology A/S) at an inlet temperature range
of 185–190°C and outlet of 85–90°C. The 1 kDaR and
1 kDaP were further concentrated (to ca 40% total solids)
before spray drying, as outlined above, in a Anhydro F1
Lab single-effect falling film evaporator (SPX Flow Tech-
nology A/S). Thus, at the end of the process a 5 kDaR,
1 kDaR, and 1 kDaP were generated.
Compositional analysis
The lipid content of the powder samples was determined
using the R€ose–Gottlieb method for lipid determination
(Vester 1962). Ash was determined gravimetrically
through modification of the International Dairy Federa-
tion (2008) method where >1 g of powder was weighed
to the nearest 0.1 mg. Dry matter was determined accord-
ing to the International Dairy Federation (1987) method
for milk and milk products. The protein content was
determined by Kjeldahl on a Foss KjeltecTM 8400 (Foss,
Hillerød, Denmark). The procedure was modified from
Koops et al. (1975) where a protein conversion factor of
6.38 was used in accordance with Merrill and Watt
(1973).
Chromatography
High performance liquid chromatography (HPLC) was
carried out using a Waters 2695 separation module, a
Waters 2487 dual wavelength absorbance detector running
on Waters Empower software (Milford, MA). Size-exclu-
sion chromatography (SEC) was carried out on a TSK Gel
G2000SW, 7.8 9 600 mm, column (TosoHaas Bioscience
GmbH, Stuttgart, Germany) using an isocratic gradient of
30% MeCN containing 0.1% trifluoroacetic acid (v/v) at a
flow-rate of 0.5 mL min1 over 60 min. Samples of Alpha
lactoalbumin (a-la), Beta lactoglobulin (b-lg) A and B,
bovine serum albumin (BSA), Lactoferrin, and Caseino-
macropeptide (CMP) (Sigma-Aldrich, Dublin, Ireland)
were used as protein standards. Ribonuclease A, Cyto-
chrome C, Aprotinin, Bacitracin, His-Pro-Arg-Trp, Leu-
Trp-Met-Arg, Bradykinin, Leu-Phe, and Tyr-Glu (Bachem
AG, Bubendorf, Switzerland) were used as molecular
weight (Mw) standards. All chromatography test samples
and standards were made up in Milli-Q water (2.5 g L1
solutions) prefiltered through 0.2 lm low protein-binding
membrane filters (Sartorius Stedim Biotech, GmbH, Goet-
tingen, Germany) and 20 lL applied to the column. The
column elute was monitored at 214 nm and 280 nm and
all solvents were filtered under vacuum through 0.45 lm
high velocity filters (Millipore Ltd., Durham, UK).
In vitro Caco-2 cell culture
The human colonic adenocarcinoma cell line, Caco-2
(American Type Culture Collection, Manassas, VA), was
maintained in Dulbecco’s modified Eagle’s medium
(DMEM) (Invitrogen Corp., San Diego, CA) with 10%
(v/v) fetal bovine serum (Invitrogen Corp.), 1% sodium
pyruvate, 1% nonessential amino acids, 1% penicillin-
streptomycin (Sigma-Aldrich Corp., St. Louis, MO) at
37°C in a humidified 5% CO2 incubator. The media was
changed every alternative day and the cells were used for
21 days after it reached 99% confluence.
Dose-dependent anti-inflammatory activity
of casein hydrolysates
Caco-2 cells were maintained for 21 days before use in
experiments in the conditions mentioned above. After
21 days, the Caco-2 cells were treated with TNFa
(10 nmol/L) to stimulate a pro-inflammatory response.
These TNFa-treated Caco-2 cells were simultaneously co-
treated with casein hydrolysates or fractions at an increas-
ing concentration of 0.01, 0.02, 0.05, 0.1, 0.5, 1, 2.5, and
5 mg/mL to optimize the concentration for the highest
anti-inflammatory activity. The Caco-2 cells stimulated
with TNFa and co-treated with the casein hydrolysates
were incubated at 37°C for 24 h in a humidified 5% CO2
incubator. After 24 h, the media was collected and IL-8
concentrations were measured using Human CXCL8/IL-8
enzyme-linked immunosorbent assay (ELISA) kit (R&D
Systems Europe, Ltd. Abingdon, UK) following the manu-
facturers protocol.
Comparison of the anti-inflammatory
activity of casein hydrolysates
Caco-2 cells were challenged with TNFa (10 nmol/L)
(Sigma-Aldrich Corp.) to stimulate a pro-inflammatory
response (control). Caco-2 cells challenged with TNFa
and simultaneously co-treated with the commercially
available anti-inflammatory steroid, Dexamethasone
(10 nmol/L) (Sigma-Aldrich Corp.), was used as a posi-
tive control for this experiment. Similarly, Caco-2 cells
were challenged with TNFa and co-treated with 1 mg/mL
of NaCAS or EH or 5 kDaR or 1 kDaR or 1 kDaP to
evaluate their anti-inflammatory property. The cell cul-
ture plates, after stimulating with TNFa and co-treating
with/without either dexamethasone or NaCAS hydroly-
sates and fractions, were incubated at 37°C for 24 h in a
humidified 5% CO2 incubator. After 24 h, the media was
collected and IL-8 levels were measured using Human
CXCL8/IL-8 ELISA kit, as mentioned in the above
section.
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Ex vivo challenge to colonic tissues
Colonic tissues from three pigs were dissected along the
mesentery and rinsed with sterile phosphate buffer saline
(PBS). Tissue sections of 1 cm3 were stripped of overly-
ing smooth muscle and placed in 1 mL of DMEM. Tis-
sue explants from each animal was: (1) incubated in the
presence of bacterial LPS, (Sigma Aldrich Corp.) at a
concentration of 10 lg/mL (challenged tissue); (2) in
the presence of LPS (10 lg/mL) and casein hydrolysate
and fractions (1 mg/mL); and (3) in sterile DMEM
(unchallenged tissue). All tissue explants were incubated
at 37°C for 90 min before being removed, blotted dried,
weighed and stored in 15 mL of RNAlater (Applied
Biosystems, Foster City, CA) overnight at 4°C. The
RNAlater was then removed prior to storing the sam-
ples at 80°C.
RNA extraction
Total RNA was extracted using GenEluteTM Mammalian
Total RNA Miniprep Kit (Sigma-Aldrich Corp.)
according to the manufacturer’s instructions. Total RNA
was subjected to DNAse I (Sigma-Aldrich Corp.)
treatment, followed by further purification using a
phenol-chloroform extraction method. The total RNA
was quantified and assessed for purity using the
NanoDrop-ND1000 Spectrophotometer (Thermo Fisher
Scientific Inc., Waltham, MA). The quality of the total
RNA was determined by visualising on an ethidium
bromide-stained 1% agarose gel.
cDNA synthesis
Total RNA (1 lg) was used for the synthesis of first
strand cDNA using the First Strand cDNA Synthesis Kit
(Qiagen Ltd. Crawley, UK) and oligo dT primers accord-
ing to the manufactures instructions. The final volume of
cDNA was adjusted to 120 lL with nuclease free water.
Quantitative real-time PCR
qPCR was carried out to quantify the following targets;
interleukins (IL1-a, IL1-b, IL-4, IL-6, IL-8, IL-10, IL-17,
IL-21), interferon (IFN-c), tumor necrosis factor (TNFa),
transforming growth factor (TGF-b) and forkhead box P3
(FOXP3). Primers used for the above mentioned targets
are presented in Table 1. The primer efficiency was deter-
mined using a serial dilution (1:4 dilution series over 7
points) of a cDNA pool, prepared by pooling an equal
quantity of cDNA from all of the experimental samples,
the efficiency of all primers was shown to be between 90
and 110%. Glyceraldehyde 3-phosphate dehydrogenase
(GAPDH), b2 microglobulin (B2M), Beta-actin (ACTB),
Peptidylprolyl isomerase A (PPIA), and 14-3-3 protein
zeta/delta (YWHAZ) were used as endogenous controls as
described by Ryan et al. (2010). All primers were designed
using Primer ExpressTM software and were synthesized by
MWG Biotech (Milton Keynes, UK). This assay was car-
ried out using 96 well fast optical plates on a 7500HT
ABI Prism Sequence Detection System (PE Applied Bio-
systems, Foster City, CA) using Fast SYBR Green PCR
Master Mix (Applied Biosystems). All reactions were
Table 1. Oligonucleotide sequences of forward and reverse primers used in qPCR.
Accession number Forward primer (50–30) Tm (°C) Reverse primer (50–30) Tm (°C)
Product
length (bp)
Efficiency
(%)
Reference genes
ACTB XM_001928093.1 GCACGGCATCATCACCAA 52.75 CCGGAGCTCGTTGTAGAAGGT 55.99 70 95.02
PPIA NM_214353.1 CGGGTCCTGGCATCTTGT 62.1 TGGCAGTGCAAATGAAAAACT 60.7 75 100.26
GAPDH AF017079.1 CAGCAATGCCTCCTGTACCA 62.2 ACGATGCCGAAGTTGTCATG 62.1 72 104.15
Cytokine genes
IL-1a NM_214029.1 CAGCCAACGGGAAGATTCTG 63.0 ATGGCTTCCAGGTCGTCAT 60.49 76 106.6
IL-1b NM_001005149.1 TTGAATTCGAGTCTGCCCTGT 60.59 CCCAGGAAGACGGGCTTT 60.94 76 104
IL-4 HQ236500.1 CCAACCCTGGTCTGCTTACTG 61.8 TTGTAAGGTGATGTCGCACTTGT 58.9 71 95
IL-6 AB194100 AGACAAAGCCACCACCCCTAA 55.27 CTCGTTCTGTGACTGCAGCTTATC 59.92 69 99.99
IL-8 NM_213867.1 TGCACTTACTCTTGCCAGAACTG 61.9 CAAACTGGCTGTTGCCTTCTT 61.7 82 95.7
IL-10 NM_214041.1 GCCTTCGGCCCAGTGAA 63.4 AGAGACCCGGTCAGCAACAA 63.1 71 95.7
IL-17A NM_001005729.1 CCCTGTCACTGCTGCTTCTG 60.57 TCATGATTCCCGCCTTCAC 60.40 57 101.2
IL-21 NM_214415 GGCACAGTGGCCCATAAATC 57.38 GCAGCAATTCAGGGTCCAAG 61.51 124 110
IFN-c NM_213948.1 TCTAACCTAAGAAAGCGGAA
GAGAA
61.12 TTGCAGGCAGGATGACAATTA 61.54 81 94.4
FOXP3 NM_001128438.1 GTGGTGCAGTCTCTGGAACAAC 60.57 AGGTGGGCCTGCATAGCA 61.18 68 94
TNF-a NM_214022.1 TGGCCCCTTGAGCATCA 62.5 CGGGCTTATCTGAGGTTTGAGA 62.8 68 91.5
TGF b NM_214015.1 AGGGCTACCATGCCAATTTCT 60.63 CGGGTTGTGCTGGTTGTACA 61.68 101 93
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performed in triplicate in a total volume of 20 lL con-
taining 10 lL Fast SYBR PCR Master mix, forward and
reverse primer (5 lmol/L) (1 lL), 8 lL diethylpyrocarbo-
nate-treated water and 1 lL of template cDNA. The ther-
mal cycling conditions were as follows, 95°C for 10 min,
40 cycles of 95°C for 15 sec and 65°C for 1 min. Dissoci-
ation analysis confirmed the specificity of the resulting
PCR products.
Normalization of data
Mean Ct values were converted into relative quantities
using the formula: Relative quantity = (PCR efficiency)DCt,
where DCt is the change in the Ct values of the sample rela-
tive to the highest expression (minimum Ct value). Rela-
tive quantities for the endogenous controls were input into
geNorm (Vandesompele et al. 2002), a normalization fac-
tor was obtained from the four most stable (M < 1.5) ref-
erence genes (GAPDH, B2M, ACTB and PPIA) for colon.
The relative quantities for the target genes were then
divided by the normalization factor to give the final nor-
malized value for each target gene in each sample.
Statistical analysis
The current study was a complete randomized design
experiment and data analyzed using the general linear
model procedure of the Statistical Analysis Institute (SAS
2004). All the data were checked initially for normality
using the PROC univariate procedure in SAS (2004). The
values from the treatment groups were compared to
unchallenged group using contrast statements. Probability
values of <0.05 were used as the criterion for statistical
significance. All results are presented in the tables as least
square means  standard error of the means (SEM).
Results
Compositional analysis and molecular
weight distribution
The compositional analysis profile of NaCAS, EH of Na-
CAS and its associated fractions are presented in Table 2.
The 0.14 lm fraction of EH did not have any significant
activity and is not presented in the results. The pilot scale
spray drying process resulted in a lower moisture content
in the EH, 5 kDaR, 1 kDaR and 1 kDaP samples relative
to the commercial NaCAS powder (P < 0.01). The addi-
tion of NaOH during the hydrolysis process increased the
ash content in the EH, 5 kDaR, 1 kDaR and 1 kDaP frac-
tions relative to the NaCAS substrate (P < 0.001). The
hydrolysis process resulted in increased ash levels and
decreased the lipid content in the NaCAS substrate, that
is, 0.80  0.06 g/100 g (NaCAS) to 0.62  0.01 g/100 g
(EH) (P < 0.05). No lipids were detected in the size-frac-
tionated products due to the use of the 0.14 lm MF
membrane. The protein content was analyzed by the Kjel-
dahl method and all samples had a protein content in the
range of 84–90 g/100 g.
The molecular weight range of the NaCAS, EH of
NaCAS and its associated fractions is presented in
Table 3. The majority of the NaCAS substrate had a
molecular weight >30 kDa. The enzymatic hydrolysis of
NaCAS decreased the abundance of material >10 kDa and
increased the abundance of material <5 kDa (P < 0.001).
Whereas, the size fractionation increased the abundance
of the material in their particular size range of 5–1 kDa
and <1 kDa and >10 kDa protein fractions were not
detected. The technique used in this process enriched the
fractions of their respective size rather than accurately
separating the proteins and the peptides according to size
(Table 3).
Dose-dependent response and optimization
of working concentration of casein
hydrolysates and associated fractions
The dose-dependent anti-inflammatory response of the
casein hydrolysate and associated fractions and the opti-
mum working concentrations are presented in Figure 1.
All the samples from this series were associated with a
dose-dependent anti-inflammatory response based on IL-
8 concentrations. The co-treatment of TNFa-stimulated
Caco-2 cells with concentrations of 1 mg/mL and above
was consistently associated with a substantial reduction in
IL-8 concentration over the 24 h period.
All the samples in this series had a consistent maxi-
mum anti-inflammatory effect at a concentration of
1 mg/mL evidenced by the reduction in IL-8 concentra-
tion in TNFa-stimulated Caco-2 cells.
Anti-inflammatory effects of NaCAS
hydrolysate and fractions in TNFa-
stimulated Caco-2 cells
All Caco-2 cells were treated with TNFa, which stimu-
lated the cells to produce IL-8 at a concentration of
110  6.60 pg/mL over a 24 h period (control). The
effects of co-treatment with either dexamethasone,
NaCAS, NaCAS EH, retentates or permeate on IL-8 con-
centration relative to TNFa-stimulated control are pre-
sented in Table 4. Co-treatment with dexamethasone
resulted in a 41.6% reduction in IL-8 concentration
(P < 0.05) relative to control. Similarly, co-treatment
with NaCAS or EH or 5 kDaR resulted in a reduction of
31.1% (P < 0.05), 31% (P < 0.05) and 32.7% (P < 0.05),
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respectively in IL-8 concentration relative to control. The
greatest effect was observed following co-treatment with
either the 1 kDaR or 1 kDaP, which resulted in the
68.7% (P < 0.01) and 66.15 (P < 0.01), respectively,
reduction in IL-8 concentration relative to control.
Anti-inflammatory effects of NaCAS
hydrolysates in LPS-stimulated porcine
colonic tissue explants
Effect of LPS on porcine colonic tissue explants
The effect of LPS challenge on the expression of a selected
panel of cytokine genes from ex vivo colonic tissues is
presented in Figure 2. The LPS-challenged porcine colo-
nic tissues were associated with increases in the normal-
ized relative quantities of IL1-a (0.424 vs. 0.064  0.091,
P < 0.05), IL1-b (0.442 vs. 0.062  0.102, P < 0.01), IL-8
(0.212 vs. 0.064  0.055, P < 0.05) and TNFa (0.234 vs.
0.024  0.037, P < 0.001) compared to unchallenged
colonic tissues. LPS-challenged tissues were also associated
with a decrease in IFN-c expression relative to unchal-
lenged tissues (0.082 vs. 0.644  0.047, P < 0.001). LPS
had no effect on IL-6, IL-10, IL-17 and TGF-b expression,
while IL-4, IL-21 and FOXP3 expression was nondetect-
able in the colonic tissues used in this study.
Effect of NaCAS hydrolysates on LPS-stimulated
porcine colonic explants
The effect of NaCAS, NaCAS EH, retentates, and perme-
ates on gene expression in the LPS-stimulated tissue is
presented in Figure 3. Co-treatment of colonic tissues
with hydrolysates EH, 5 kDaR and 1 kDaR was associated
with a downregulation of IL1-a (0.086, 0.021, 0.028 vs.
0.424  0.083, P < 0.05) and TNFa (0.101, 0.123, 0.128
vs. 0.234  0.034, P < 0.05) expression relative to LPS-
challenged tissues. Similarly, co-treatment with 5 kDaR
and 1 kDaR hydrolysates was associated with a downre-
gulation of IL-1b (0.151, 0.096 vs. 0.442  0.093,
P < 0.05) and IL-8 (0.033, 0.068 vs. 0.212  0.050,
P < 0.05) expression relative to LPS-challenged tissues.
While the LPS challenge had no effect on the expres-
sion of IL-10, IL-17 and TGF-b, as presented in Fig-
ure 2, co-treatment with casein hydrolysates had
significant effects on IL-10 and TGF-b expression,
whereas co-treatment with NaCAS had significant effects
on only IL-17 expression relative to unchallenged tissues,
presented in Figure 4. The treatment of porcine colonic
tissues with EH, 5 kDaR, 1 kDaR and 1 kDaP caused a
down-regulation of IL-10 expression (0.083, 0.056,
0.063, 0.098 vs. 0.194  0.029, P < 0.05) relative to
Table 3. Molecular weight distribution of sodium caseinate (NaCAS), NaCAS enzyme hydrolysate and its retentates and permeate protein powders.
Test sample
Molecular weight distribution (%)1
>30 kDa 30–10 kDa 10–5 kDa 5–1 kDa <1 kDa
NaCAS 83.59  0.22 14.55  0.01 1.20  0.01 0.61  0.02 0.06  0.01
EH 1.90  0.01* 1.28  0.01* 3.33  0.06* 46.17  0.01* 47.33  0.01*
5 kDaR 0.09  0.01* 0.31  0.01* 1.93  0.12* 56.25  0.02* 41.52  0.01*
1 kDaR ND 0.06  0.01* 0.36  0.01* 28.67  0.01* 70.90  0.10*
1 kDaP ND ND 0.12  0.01* 22.23  0.03* 77.62  0.04*
ND, not detected.
1Molecular weight distribution was determined by SEC (TSK G2000SW) where the powders were reconstituted in distilled H2O to 2.5 g L
1
protein and subsequently filtered through a 0.45 lm filter prior to the application of 20 lL of this solution to the column.
*P < 0.01.
Table 2. Compositional characteristics of sodium caseinate (NaCAS), NaCAS enzyme hydrolysate and its retentates and permeate protein
powders.
Test sample Moisture (%) Ash (g/100 g) Lipid (g/100 g) Protein1(g/100 g)
NaCAS 3.11  0.09 3.90  0.10 0.80  0.06 88.66  0.10
EH 1.87  0.18** 5.41  0.01*** 0.62  0.01* 89.38  0.08**
5 kDaR 2.86  0.39 6.80  0.12*** ND 87.97  0.91
1 kDaR 1.47  0.26** 9.20  0.07*** ND 86.13  1.63
1 kDaP 2.00  0.10** 9.40  0.04*** ND 84.19  1.25*
ND, not detected.
1Kjeldahl conversion factor used was 6.38.
*P < 0.05, **P < 0.01, ***P < 0.001.
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unchallenged tissues. Colonic tissues co-treated with Na-
CAS was associated with an increase in IL-17 (0.358 vs.
0.136  0.042, P < 0.05) expression relative to unchal-
lenged tissues. The co-treatment with EH, 5 kDaR and
1 kDaR hydrolysates was associated with a down-regula-
tion of TGF-b (0.121, 0.181, 0.105 vs. 0.382  0.071,
P < 0.05) expression in colonic tissues relative to
unchallenged tissues.
Discussion
IL-8 is a chemotactic cytokine and an established marker
for inflammation in the gastrointestinal system (Harada
et al. 1994; Mahida 2000). Increased serum IL-8 has been
associated with chronic inflammatory diseases including
IBD, and is a potential target for immunotherapeutic
approaches (Skov et al. 2008). The ability of the NaCAS
Table 4. Effect on IL-8 production in fully differentiated Caco-2 cells stimulated with TNFa and co-treated with dexamethasone, sodium caseinate
(NaCAS) and NaCAS enzyme hydrolysate, retentates, and permeate for 24 h.
Treatment IL-8 conc. (pg/mL) SEM % reduction1 Significance
TNFa 110.0 6.60
TNFa + Dexamethasone 68.4 5.87 41.6 *
TNFa + NaCAS 75.8 3.35 31.1 *
TNFa + EH 79.0 5.11 31.0 *
TNFa + 5 kDaR 77.3 4.44 32.7 *
TNFa + 1 kDaR 41.3 8.00 68.7 **
TNFa + 1 kDaP 43.9 7.82 66.1 **
Cell lysate was collected after 24 h of treatment and ELISA was performed.
1The % reduction values are relative to control (TNFa stimulated) Caco-2 cells.
*P < 0.05, **P < 0.01, n = 3.
Figure 1. Dose dependent reduction of IL-8 concentration by a milk hydrolysate series (NaCAS, EH, 5 kDaR, 1 kDaR and 1 kDaP). Each data
point indicates n = 3  standard error. The fully differentiated Caco-2 cells were challenged with TNFa and co-treated with milk hydrolysates for
24 h, cell lysate collected after 24 h and ELISA performed.
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hydrolysates to suppress IL-8 in the TNFa-stimulated
Caco-2 cell system was an initial strong indicator of the
anti-inflammatory activity of these hydrolysates, with
both the 1 kDaR and 1 kDaP suppressing IL-8 secretion
relative to NaCAS, NaCAS EH, 5 kDaR, and dexamentha-
sone. This observation was further supported by the fact
that the hydrolysate fractions, in particular the 5 kDaR
and 1 kDaR maintained their anti-inflammatory proper-
ties in the ex vivo colonic system, reducing the expression
of a panel of pro-inflammatory cytokines IL1-a, IL1-b,
IL-8, IL-10, TNFa and TGF-b in LPS-challenged porcine
colonic tissues. The fact that the expression of all of these
cytokines play a role in the progression of inflammatory
conditions such as IBD raise the possibility that the
hydrolysate fractions identified in this study may have the
potential to alleviate the recurrence of IBD-like condi-
tions.
The functional similarity of Caco-2 cells to colonic
enterocytes, along with their ability to elicit a pro-inflam-
matory reaction in response to stimulants like H2O2, LPS
and TNFa makes them a useful in vitro model for the
study of effects of food ingredients on the gut epithelial
layer (Tanoue et al. 2008). In this study and in the previ-
ous study by Piccolomini et al. (2012), modified milk
proteins have been shown to suppress IL-8 concentrations
in cells already exhibiting inflammation. The anti-inflam-
matory effects of fractions in this study indicate that the
bioactive molecules within these fractions could be useful
agents in the re-establishment of GIT homeostasis, which
may have been lost due to disregulated inflammation.
While all the casein hydrolysates induced a reduction in
IL-8 production, the greatest anti-inflammatory activity
was observed in response to exposure to the 1 kDaR and
1 kDaP fractions. This greater anti-inflammatory activity
is most likely attributable to the <1-kDa protein fractions,
which are enriched in these two fractions.
The anti-inflammatory properties of casein hydrolysates
were subsequently evaluated in an ex vivo system using
porcine colonic tissue explant system. The ex vivo system
has several advantages over the in vitro Caco-2 cell sys-
tem. Firstly, porcine colonic tissue ex vivo closely repre-
sents the in vivo complexity of colonic tissue, which is
composed of heterogeneous cell types. Secondly, ex vivo
colonic tissue response to inflammation inducing agents
such as LPS and this response mimics a microbial chal-
lenge within the gut. LPS acts via the TLR4/MD-2 com-
plex and can stimulate a number of pro-inflammatory
cytokines in the tissue explants (Moue et al. 2008; Yuk
and Jo 2011) as some of these signaling factors would
otherwise have negligible expression levels. In the present
study, ex vivo treatment of porcine colonic tissues with
LPS resulted in an increase in the expression of the pro-
inflammatory cytokine genes: IL1-a, IL1-b, IL-8, and
TNFa. In the gut of a live animal/human, these pro-
inflammatory cytokines are generally secreted by macro-
phages present under the mucosal layer of the intestine
(Mahida 2000). The ex vivo results from this study indi-
cate that the 1 kDaR reduced the expression of cytokines
IL1-a, IL1-b, IL-8, IL-10, TNFa, and TGF-b in porcine
colonic tissues. Increased expression of the pro-inflamma-
tory cytokines has been associated with a number of met-
abolic syndromes (Cam and de Mejia 2012) in addition
to chronic inflammation of the bowel in humans (Skov
et al. 2008). In line with the Caco-2 cell system study,
both the 5 kDaR and 1 kDaR hydrolysates downregulated
IL-8 gene expression in colonic explants. IL-8 is produced
in the intestinal mucosa by epithelial cells, macrophages,
and fibroblasts (Daig et al. 1996). Human subjects exhib-
iting clinical signs of ulcerative colitis (UC) were shown
to have decreased levels of IL-8 (upon receiving the parti-
tion-herb moxibustion) in their mucosae which was coin-
cident with improvements in the histological profile of
the colon (Zhou et al. 2009). Hence, casein hydrolysates
could have potential as therapeutic agents in the treat-
ment of inflammatory diseases of the GIT that are linked
to an excessive activity of IL-8, for example, UC. The EH,
5 kDaR and 1 kDaR caused a down-regulation of IL1-a
expression, a cytokine which mediates immune and
inflammatory responses and is generally produced by
macrophages, monocytes, neutrophils, and endothelial
cells (Dinarello 1994). Two casein hydrolysate fractions
(5 kDaR and 1 kDaR) also downregulated the IL1-b gene
expression in this study. IL-1b is also a member of IL-1
Figure 2. Difference in expression of a selected panel of cytokine genes
between unchallenged and Lipopolysaccharides (LPS)-challenged ex vivo
colonic tissues. The red dots represent significant upregulated genes
(P < 0.05), the blue dot represents significant downregulated gene
(P < 0.05) and black dots represent genes not affected by LPS (P > 0.05).
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family and plays an important role in the Th17-mediated
immune response (Chung et al. 2009). In this study,
TNFa gene expression was also downregulated in
response to EH, 5 kDaR and 1 kDaR. TNFa, is a key
player in inflammation implicated in the progression of
IBD (Skov et al. 2008) Serum levels of TNFa produced
from macrophages or monocytes is correlated with the
clinical progression of IBD, further supporting the use of
anti-TNFa antibodies in IBD therapy (Chaparro et al.
2012). Hence, the downregulation of both of these cyto-
kines provides valuable evidence of the anti-inflammatory
properties of the 5 kDaR and 1 kDaR.
In disease conditions such as IBD, progression of T-cell
differentiation and inhibition depends upon a number of
cytokines including, IL-4, IFN-c, and TGF-b (Zhu and
Paul 2008). Although in this study, the expression of IL-4
and IFN-c genes was unaffected by milk hydrolysates,
TGF-b expression was altered. TGF-b regulates growth,
differentiation and function of immune cells by inhibiting
T cells and switching on B cells (Maloy and Powrie
2011). Greater expression of TGF-b has been reported in
the intestines of IBD patients (Franke et al. 2008) and its
excessive production has been linked to increased fibrosis,
stimulation of collagen production, and increased inci-
dences of carcinogenesis (Sebens and Sch€afer 2012).
Our study indicated that EH and all the size fractions of
casein hydrolysate downregulated IL-10 expression in por-
cine colonic explant. A genome-wide association study
identified IL-10 as a susceptibility locus for the develop-
ment of IBD in humans (Franke et al. 2008). It has also
been reported that local levels of IL-10 mRNA were higher
in mucosa of IBD patients (Niessner and Volk 2008).
Recent reports have indicated that Treg cells play a role in
the regulation of IL-10 production. IL-10 is a factor, which
generally suppresses inflammatory immune responses and
has been shown to be important in the maintenance of
immune homeostasis within the gut (Tanoue and Honda
2012). In situ analysis of healthy human colonic mucosa
using qPCR and immunoblot analysis has indicated that
IL-10 functions as an immunomodulatory cytokine and
possesses both immunosupressive and pro-inflammatory
functions depending on the context (Jarry et al. 2008).
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Figure 3. Effect of NaCAS, EH, 5 kDaR, 1 kDaR or 1 kDaP on relative quantity (RQ) of a selected panel of cytokine genes stimulated by LPS
challenge for 3 h in porcine colonic tissue explant. After challenge with LPS and treatment with milk hydrolysates, total RNA was extracted, cDNA
synthesised and RT-qPCR was performed to quantify the selected panel of genes. RQ values of treatments with NaCAS, EH, 5 kDaR, 1 kDaR or
1 kDaP compared to LPS challenged control, error bars indicate SE. *P < 0.05, **P < 0.01.
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IL-10 regulates immune function through T cells, B cells,
dendritic cells, and intestinal epithelial cells. This cytokine
also plays an important role in the inhibition of the Th1
cells as well as diminishing the antigen presenting capacity
of monocytes (Kaser et al. 2010).
The potential of the NaCAS hydrosylate fractions to
suppress the inflammatory cytokines has particular rele-
vance to inflammatory condition of the GIT including
IBD. IBD represents a group of painful, debilitating dis-
ease conditions of the lower gastrointestinal tract that
affects an estimated 2.4 million people in Europe (Cosnes
et al. 2011). While IBD is known to be a problem for
adults, recent analyses highlight that fact that the inci-
dence of IBD is also increasing in children (Langholz
2010; Malaty et al. 2010). A characteristic of IBD is an
exaggerated immune response to enteric microorganisms,
with a resultant overproduction of pro-inflammatory
cytokines and chemokines. These signalling molecules
induce inappropriate recruitment and infiltration of lym-
phocytes and granulocytes to the colonic epithelial
mucosa eliciting localized inflammation (Kim et al. 2010).
While therapeutics are currently available for IBD, a key
feature of the disease is a tendency for relapse, and a
recurrent pattern of inflammation (Malaty et al. 2010).
The identification of natural modulatory bioactives, such
as the NaCAS hydrosylate fractions identified in this
study, that can be taken in the diet which can retain
inflammatory homeostasis would be of great benefit in
decreasing the incidence of IBD recurrence, and warrants
further research.
Conclusion
The study demonstrates the consistent anti-inflammatory
bioactivity of a 1-kDaR of NaCAS hydrolysate in both in vi-
tro and ex vivo colon models. The 1-kDaR was associated
with a reduced IL-8 concentration in vitro and down regu-
lation of a panel of pro-inflammatory cytokines in the ex
vivo colonic explant system. These findings indicate that
further analysis of this 1-kDaR of NaCAS hydrolysate
would be valuable in the exploration of its potential as an
anti-inflammatory functional food ingredient.
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